Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2017 3
2018 1
2019 3
2020 1
2021 1
2022 3
2023 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Genetics, Cytogenetic Testing and Conventional Karyotype.
Ozkan E, Lacerda MP. Ozkan E, et al. Among authors: lacerda mp. 2023 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 33085440 Free Books & Documents.
Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH).
Chiattone CS, Marques FM, Buccheri V, Yamamoto M, Fortier SC, Ikoma-Colturato MRV, Hamerschlak N, Figueiredo VLP, da Silveira TMB, Costa A, Laks D, Schaffel R, Barreto WG, Scheliga A, Fernandes PA, Nabhan SK, Gaiolla RD, Gonçalves MV, de Farias DLC, Ribeiro G, de Lacerda MP, Arrais-Rodrigues C; Brazilian Group of Chronic Lymphocytic Leukemia. Chiattone CS, et al. Among authors: de lacerda mp. Hematol Transfus Cell Ther. 2025 Apr-Jun;47(2):103822. doi: 10.1016/j.htct.2025.103822. Epub 2025 May 9. Hematol Transfus Cell Ther. 2025. PMID: 40347842 Free PMC article.
Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trial.
Hungria V, Hus M, Fu C, Zherebtsova V, Ward C, Ho PJ, Mikulski D, Muronova L, Cerchione C, Loubert A, Bunod L, M'Hari M, Pirooz N, Rogers R, Lin CP, Roy-Ghanta S, Opalinska JB, Purser M, McKeown A, McNamara S, Baig H, Eccersley L, Pompilus F, Mateos MV; DREAMM-7 trial study group. Hungria V, et al. Lancet Haematol. 2025 Aug;12(8):e599-e610. doi: 10.1016/S2352-3026(25)00163-2. Epub 2025 Jul 15. Lancet Haematol. 2025. PMID: 40680752 Clinical Trial.
Chronic lymphocytic leukemia in Brazil: A retrospective analysis of 1903 cases.
Gonçalves MV, Rodrigues CA, Lorand Metze IGH, Lacerda MP, de Lourdes Lopes Ferrari Chauffaille M, Azevedo A, Machado C, Chiattone CS, Fortier S, Perobelli L, Ikoma MRV, Clementino N, Hamerschlak N, Sthel VM, Ommati LVM, de Farias DLC, Duarte FB, Buccheri V, de Azambuja AP, de Almeida DR, Figueiredo VLP, Yamamoto M. Gonçalves MV, et al. Among authors: lacerda mp. Am J Hematol. 2017 Aug;92(8):E171-E173. doi: 10.1002/ajh.24779. Epub 2017 Jun 9. Am J Hematol. 2017. PMID: 28474845 Free article. No abstract available.
18 results